China plans to vaccinate 50 million people with its vaccine, claims one million COVID-19 shots already given
Chinese health officials discussed rolling out vaccinations in two batches before January 15 and February 5 in a conference call earlier this week, according to people close to the matter.
Representative image
China announced that it has already administered more than 1 million COVID-19 vaccines since July. It now plans a phased rollout that will initially focus on workers at higher risk of infection, reported Bloomberg.
According to the news report, vaccines developed by Sinovac Biotech Ltd. and the state-owned China National Biotec Group Co. have been dispensed in the country since they were granted emergency-use authorization in July.
China says 1 million Covid-19 vaccines already given; plans further shots theedgemarkets.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theedgemarkets.com Daily Mail and Mail on Sunday newspapers.
Share:
Pfizer Inc (NYSE: PFE) and
BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine will be administered in China alongside home-made options, Bloomberg reported Tuesday.
What Happened: Local pharmaceutical firm
Shanghai Fosun Pharmaceutical (Group) Co, Ltd (OTC: SFOSF) which signed an agreement with BioNTech in March will pay the German company $300 million (EUR 250 million) for an initial 50 million doses, according to Bloomberg.
Pfizer’s German partner will supply no less than 100 million doses to China by 2021, Fosun informed the Hong Kong Stock Exchange, as per Bloomberg.
Meanwhile, COVID-19 vaccines made by China National Biotec Group Co and Sinovac Biotech Ltd are reportedly close to approval by drug regulators in China and 1.6 billion doses are expected to be manufactured in 2021.
China secures 100 million doses of covid-19 vaccine co-developed by Pfizer and BioNTech
While the shot is globally known as the one co-developed by Pfizer, the US company is not involved in the agreement.
(AP)Premium
. Updated: 16 Dec 2020, 09:56 PM IST Bloomberg
While trial results indicate the Pfizer-BioNTech shot is 95% effective against Covid-19, none of the Chinese makers has officially announced efficacy data yet
Share Via
Read Full Story
A Chinese drugmaker has secured 100 million doses of the coronavirus vaccine co-developed by Pfizer Inc. and BioNTech SE, as the country seeks overseas shots in addition to home-made ones to ensure immunization for the world’s most populous nation.